Aurinia Pharmaceuticals Inc
NASDAQ:AUPH 4:00:00 PM EDT
| Market Cap (Intraday) | 1.03B |
| Current PE | N/A |
| Forward PE | 141.6 |
| 2yr Forward PE | 16.86 |
| 10-Day MA | $7.01 |
| 50-Day MA | $6.65 |
| 200-Day MA | $6.15 |
Aurinia Pharmaceuticals Inc Stock, NASDAQ:AUPH
14315 � 118 Avenue, Suite 140, Edmonton, Alberta T5L 4S6
Canada
Phone: +1.250.744.2487
Number of Employees: 300
Description
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.